TY  - JOUR
AU  - Rivera-Izquierdo, Mario
AU  - Valero-Ubierna, María Del Carmen
AU  - R-delAmo, Juan Luis
AU  - Fernández-García, Miguel Ángel
AU  - Martínez-Diz, Silvia
AU  - Tahery-Mahmoud, Arezu
AU  - Rodríguez-Camacho, Marta
AU  - Gámiz-Molina, Ana Belén
AU  - Barba-Gyengo, Nicolás
AU  - Gámez-Baeza, Pablo
AU  - Cabrero-Rodríguez, Celia
AU  - Guirado-Ruiz, Pedro Antonio
AU  - Martín-Romero, Divina Tatiana
AU  - Láinez-Ramos-Bossini, Antonio Jesús
AU  - Sánchez-Pérez, María Rosa
AU  - Mancera-Romero, José
AU  - García-Martín, Miguel
AU  - Martín-delosReyes, Luis Miguel
AU  - Martínez-Ruiz, Virginia
AU  - Jiménez-Mejías, Eladio
PY  - 2020
DO  - 10.1016/j.medcli.2020.06.025
UR  - http://hdl.handle.net/10668/16075
T2  - Medicina clinica
AB  - In the last months great efforts have been developed to evaluate the more efficient therapeutic agents in the management of patients with COVID-19. Currently, no specific drug combination has consistently demonstrated an association with mortality....
LA  - en
KW  - COVID
KW  - Hospitalizados
KW  - Hospitalized
KW  - Mortalidad
KW  - Mortality
KW  - SARS-CoV-2
KW  - Tratamientos
KW  - Treatments
KW  - Adrenal Cortex Hormones
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Antibodies, Monoclonal, Humanized
KW  - Antiviral Agents
KW  - Azithromycin
KW  - Betacoronavirus
KW  - COVID-19
KW  - Comorbidity
KW  - Coronavirus Infections
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Hydroxychloroquine
KW  - Inpatients
KW  - Lopinavir
KW  - Male
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Proportional Hazards Models
KW  - Retrospective Studies
KW  - Ritonavir
KW  - SARS-CoV-2
KW  - Spain
KW  - Treatment Outcome
KW  - COVID-19 Drug Treatment
TI  - Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality.
T2  - Agentes terapéuticos utilizados en 238 pacientes hospitalizados por COVID-19 y su relación con la mortalidad.
TY  - research article
VL  - 155
ER  -